Skip to main content
Article thumbnail
Location of Repository

Cellular localization of Y-box binding protein 1 in brain tissue of rats, macaques, and humans

By Bernadette Unkrüer, Anton Pekcec, Christina Fuest, Andrea Wehmeyer, Maria S Balda, Anja Horn, Wolfgang Baumgärtner and Heidrun Potschka
Topics: Research Article
Publisher: BioMed Central
OAI identifier:
Provided by: PubMed Central

Suggested articles


  1. (2005). BH: Y-box binding protein, YB-1, as a marker of tumor aggressiveness and response to adjuvant chemotherapy in breast cancer.
  2. (2008). ButtnerEnnever JA: Perioculomotor cell groups in monkey and man defined by their histochemical and functional properties: reappraisal of the Edinger-Westphal nucleus.
  3. (2004). CC: YB-1 is upregulated during prostate cancer tumor progression and increases P-glycoprotein activity. Prostate
  4. (2006). Expression and polysome association of YB-1 in various tissues at different stages in the lifespan of mice. Biochim Biophys Acta
  5. (2007). Gene expression profile in temporal lobe epilepsy. Neuroscientist
  6. (1999). H: Is nuclear expression of Y box-binding protein-1 a new prognostic factor in ovarian serous adenocarcinoma? Cancer
  7. (2001). HD: Hyperthermia-induced nuclear translocation of transcription factor YB-1 leads to enhanced expression of multidrug resistance-related ABC transporters.
  8. (1992). HD: Tissue restricted expression and chromosomal localization of the YB-1 gene encoding a 42 kD nuclear CCAAT binding protein. Nucleic Acids Res
  9. (2002). HD: Y-box factor YB-1 predicts drug resistance and patient outcome in breast cancer independent of clinically relevant tumor biologic factors HER2, uPA and PAI-1.
  10. (2005). Increased nuclear localization of transcription factor Y-box binding protein 1 accompanied by up-regulation of P-glycoprotein in breast cancer pretreated with paclitaxel. Clin Cancer Res
  11. (2003). Isolation and characterization of brain Y-box protein: developmentally regulated expression, polyribosomal association and dendritic localization. Brain Res Mol Brain Res
  12. (1998). Iwamoto Y: Nuclear expression of YB1 protein correlates with P-glycoprotein expression in human osteosarcoma. Clin Cancer Res
  13. (2003). Kohno K: The basic and clinical implications of ABC transporters, Y-box-binding protein-1 (YB-1) and angiogenesisrelated factors in human malignancies. Cancer Sci
  14. (2003). Kuwano M: The pleiotropic functions of the Y-box-binding protein, YB-1. Bioessays
  15. (2006). NE: Altered expression of pro-inflammatory and developmental genes in the fetal brain in a mouse model of maternal infection. Neurosci Lett
  16. (2003). Nuclear expression of Y-box-binding protein-1 correlates with P-glycoprotein and topoisomerase II alpha expression, and with poor prognosis in synovial sarcoma.
  17. (1997). Nuclear localization and increased levels of transcription factor YB-1 in primary human breast cancers are associated with intrinsic MDR1 gene expression. Nat Med
  18. (2004). Okano H: Sox21 is a repressor of neuronal differentiation and is antagonized by YB-1. Neurosci Lett
  19. (2004). Ovchinnikov LP: Structural organization of mRNA complexes with major core mRNP protein YB-1. Nucleic Acids Res
  20. (2006). PH: Y-box binding protein 1: providing a new angle on translational regulation. Cell Cycle
  21. (2006). Pitkanen A: Epileptogenesisrelated genes revisited. Prog Brain Res
  22. (2005). Potschka H: Drug resistance in brain diseases and the role of drug efflux transporters. Nat Rev Neurosci
  23. (2008). Potschka H: Effect of aging on neurogenesis in the canine brain. Aging Cell
  24. (2008). Potschka H: Seizure-induced up-regulation of P-glycoprotein at the bloodbrain barrier through glutamate and cyclooxygenase-2 signaling. Mol Pharmacol
  25. (2007). Stavrovskaya AA: Development of drug resistance in the population of colon cancer cells under the effect of multifunctional protein YB-1. Bull Exp Biol Med
  26. (1995). The safety of interstitial chemotherapy with BCNU-loaded polymer followed by radiation therapy in the treatment of newly diagnosed malignant gliomas: phase I trial.
  27. (2007). Tsuneyoshi M: Prognostic implications of the nuclear localization of Y-box-binding protein-1 and CXCR4 expression in ovarian cancer: their correlation with activated Akt, LRP/MVP and P-glycoprotein expression. Cancer Sci
  28. (2006). W: A comparison of immunohistochemical and silver staining methods for the detection of diffuse plaques in the aged canine brain. Neurobiol Aging
  29. (2007). What makes tumors multidrug resistant? Cell Cycle

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.